male or female patients aged 35-75 years with type 2 diabetes mellitus and recent evidence of persistent microalbuminuria

patients with a median (of 3 samples) timed overnight UAER in the microalbuminuric range of 20-200 g/min in the formal screening period prior to entry

patients who give written, signed, informed consent.

patients with/without mild /moderate hypertension.

patients who are not on hypertensive treatment, or if they are already on treatment, those who accept to enter a 3 weeks no-treatment wash-out period before switching their treatment.

patients without any accompanying systemic disease

A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril

What this study is about